Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease [Phase 2]
A Phase 2 study evaluating lecanemab in early Alzheimer's disease has completed and posted results, reporting safety, tolerability, and effi…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Repurposing Siponimod for Alzheimer's Disease [Phase 2]
A Phase 2 trial is evaluating repurposing siponimod for Alzheimer's disease, with recruitment ongoing for Alzheimer's disease and related mi…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Coordinated Emergency Department Transitions [NA]
A Brown University-sponsored clinical trial evaluating coordinated emergency department transitions for patients with Alzheimer's disease or…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias [Phase 2]
Phase 2 trial investigating neuroinflammation as a contributing pathology in Alzheimer's disease dementia and related dementias; enrollment …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: High-Velocity Resistance Training for Brain Blood Flow and Cognitive Function in Older Adults [NA]
A clinical trial evaluating high-velocity resistance training to improve brain blood flow and cognitive function in older adults at risk for…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care [NA]
Clinical trial update for NCT06079203 (ED-LEAD) sponsored by NYU Langone Health, an active, not recruiting study aimed at transforming emerg…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: 10-Year Survival After Acute Hip Fracture in Patients With Preclinical/Clinical Alzheimer Pathology
This clinical trial update reports on 10-year survival after acute hip fracture in patients with preclinical or clinical Alzheimer's patholo…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease [NA]
This clinical trial update describes a study on locomotion adaptation deficits in older adults with Alzheimer's disease and mild cognitive i…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Couples Lived Experience
This update reports a completed clinical trial examining the lived experiences of couples affected by Alzheimer’s disease and related dement…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines - (DREAM) Probenecid vs Allopurinol
A completed clinical trial comparing probenecid and allopurinol for repurposing toward Alzheimer's therapies; results posted February 27, 20…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease [Phase 2]
The open-label extension study of XPro1595 in Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Improving Sleep and AD Biomarkers [NA]
A completed Emory University-sponsored clinical trial assessed sleep and Alzheimer's disease biomarkers in people with Mild Cognitive Impair…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: BCT Intervention For Walking Habit Among Caregivers of People With AD/ADRD [NA]
A clinical trial tests a Behavioral Change Technique to promote walking among caregivers of people with Alzheimer disease and related dement…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER)
An ongoing clinical trial evaluating blood-based biomarkers for Alzheimer's disease and neuro-injury. It aims to estimate associations betwe…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease [NA]
A clinical trial update reports termination of the home-based transcranial direct current stimulation (tDCS) study in frontotemporal dementi…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A BCT Intervention for an Hourly Activity Habit Among Caregivers for Persons With AD/ADRD [NA]
ClinicalTrials.gov entry describes a behavioral intervention using a behavior-change technique to establish hourly activity habits among car…
-
EMA approval · 2026-02-26EMA Authorised: Kisunla (donanemab) — Eli Lilly Nederland B.V.
EMA authorised Kisunla (donanemab) for Alzheimer's disease and cognitive dysfunction in the European Union. Eli Lilly Nederland B.V. is the …
-
EMA approval · 2026-02-25EMA Authorised: DaTSCAN (ioflupane (123l)) — GE Healthcare B.V.
EMA authorised DaTSCAN, a radiopharmaceutical imaging agent (ioflupane I-123) by GE Healthcare B.V., for use in the diagnostic assessment of…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Pharmacological Enhancement of Glymphatic Function in Humans [Phase 1, Phase 2]
This update reports the completion of Phase 1/2 clinical trials evaluating a pharmacological approach to enhance glymphatic function in huma…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease [Phase 2]
A long-term extension study of AL002 in Alzheimer's disease was terminated, and the study results have been posted.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease [Phase 2, Phase 3]
A trial update describing a Phase 2/3 study to evaluate the efficacy, safety, and tolerability of dronabinol oral solution for agitation in …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3) [NA]
Duke University is conducting an exploratory clinical trial comparing a high-performance, low-cost optical coherence tomography system, with…
-
EMA approval · 2026-02-24EMA Authorised: Exelon (rivastigmine) — Novartis Europharm Limited
The European Medicines Agency authorised Exelon (rivastigmine) for dementia including Alzheimer's disease and Parkinson's disease, with Nova…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease [Phase 3]
Phase 3 trial examining Semaglutide's impact on immune and biological processes in Alzheimer's disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine [Phase 1]
Phase I clinical trial of AV-1959R, an Abeta-targeting Alzheimer's vaccine, has completed and results have been posted.